These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 12112079)

  • 41. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
    Sergeant N; David JP; Lefranc D; Vermersch P; Wattez A; Delacourte A
    FEBS Lett; 1997 Aug; 412(3):578-82. PubMed ID: 9276470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment.
    Probst A; Tolnay M; Langui D; Goedert M; Spillantini MG
    Acta Neuropathol; 1996 Dec; 92(6):588-96. PubMed ID: 8960316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pick's complex and FTDP-17.
    Kertesz A
    Mov Disord; 2003 Sep; 18 Suppl 6():S57-62. PubMed ID: 14502657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies.
    Arima K
    Neuropathology; 2006 Oct; 26(5):475-83. PubMed ID: 17080728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick's disease.
    Puig B; Vinals F; Ferrer I
    Acta Neuropathol; 2004 Mar; 107(3):185-9. PubMed ID: 14689204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitration of tau protein is linked to neurodegeneration in tauopathies.
    Horiguchi T; Uryu K; Giasson BI; Ischiropoulos H; LightFoot R; Bellmann C; Richter-Landsberg C; Lee VM; Trojanowski JQ
    Am J Pathol; 2003 Sep; 163(3):1021-31. PubMed ID: 12937143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pick's disease pathology of a missense mutation of S305N of frontotemporal dementia and parkinsonism linked to chromosome 17: another phenotype of S305N.
    Kobayashi K; Hayashi M; Kidani T; Ujike H; Iijima M; Ishihara T; Nakano H; Sugimori K; Shimazaki M; Kuroda S; Koshino Y
    Dement Geriatr Cogn Disord; 2004; 17(4):293-7. PubMed ID: 15178939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Signature tau neuropathology in gray and white matter of corticobasal degeneration.
    Forman MS; Zhukareva V; Bergeron C; Chin SS; Grossman M; Clark C; Lee VM; Trojanowski JQ
    Am J Pathol; 2002 Jun; 160(6):2045-53. PubMed ID: 12057909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
    Belrose JC; Masoudi R; Michalski B; Fahnestock M
    Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exon 3 insert of tau protein in neurodegenerative diseases.
    Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
    Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress in hereditary tauopathies: a mutation in the Tau gene (G389R) causes a Pick disease-like syndrome.
    Ghetti B; Murrell JR; Zolo P; Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():52-62. PubMed ID: 11193177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Threonine
    Moszczynski AJ; Yang W; Hammond R; Ang LC; Strong MJ
    Acta Neuropathol Commun; 2017 Jan; 5(1):6. PubMed ID: 28077166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunocytochemical and ultrastructural studies of Pick's disease.
    Murayama S; Mori H; Ihara Y; Tomonaga M
    Ann Neurol; 1990 Apr; 27(4):394-405. PubMed ID: 2162145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
    Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
    Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.
    Kyalu Ngoie Zola N; Balty C; Pyr Dit Ruys S; Vanparys AAT; Huyghe NDG; Herinckx G; Johanns M; Boyer E; Kienlen-Campard P; Rider MH; Vertommen D; Hanseeuw BJ
    Nat Commun; 2023 Jun; 14(1):3706. PubMed ID: 37349319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
    Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
    Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
    Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
    Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.
    Delacourte A; Sergeant N; Wattez A; Gauvreau D; Robitaille Y
    Ann Neurol; 1998 Feb; 43(2):193-204. PubMed ID: 9485060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.